After in vitro ischemia, the content of adenosine triphosphate in myocardial bioptates from patients with heart diseases is reduced. This reduction is more pronounced in patients with coronary heart disease than in patients with rhythm disturbances. Administration of the antioxidant preparation histochrome to patients with coronary heart disease preserves ATP during ischemic exposure.
Key Words: myocardium; ischemia; ATP; lipid peroxidation; antioxidantsSurgery, a radical treatment of coronary insufficiency in coronary heart disease (CHD), is associated with risk of some grave complications, especially in early postoperation period [1]. Apart from operation wound, these complications can be caused by reperfusion damage to the myocardium [8]. A prospective way of preventing this damage is the use of antioxidant preparations [5,9]. However, recent in vitro experiments have shown that ischemia-and reperfusioninduced disturbances of myocardial contractility, in particular, myocardial contracture are due not only to altered permeability of cell membranes, but also depend on the ATP pool remaining in cardiomyocytes (CMC) before reperfusion [12]. In light of this is was interesting to evaluate the effect of acute ischemia during heart surgery and antioxidant therapy on myocardial ATP content in CHD patients.
MATERIALS AND METHODSExperiments were carried out on fragments from right auricle obtained during aortocoronary bypass The fragments were washed from blood with cooled physiological saline and cut into 2 portions: one was immediately frozen in liquid nitrogen, while the other was placed to a humidified chamber (20~ for 60 rain and then frozen in liquid nitrogen. The latter procedure adequately reproduces the conditions of aortocoronary bypass operation.Some patients with CHD (n=9) were prepared for operation according to routine scheme, while others (n=8) additionally received two intravenous injections of 3% histochrome (HC) in a dose of 1 mg/kg (24 h prior to operation and in the operating room). Histochrome, a novel Russian-manufactured antioxidant, was kindly provided by Dr. A. V. Lebedev (Russian Research and Manufacturing Cardio, logy Association). Fragments obtained from patients without CHD and operated for cardiac rhythm disturbances (n=6) served as the control.